Canada

Search form

Hologic Signs Multi-Year Cervical Screening Contract with AML Laboratory

Six-year contract with large Belgium lab includes the purchase of Hologic ThinPrep test and automated processing equipment

Hologic, Inc. (Hologic or the Company) has entered into a six-year contract with AML Laboratory in Antwerp, Belgium for its ThinPrep and Cervista automated cervical screening products. AML Laboratory is one of the largest laboratories in Belgium and part of Sonic Healthcare Benelux, a division of Sonic Healthcare, one of the world’s largest medical diagnostics companies. 

Hologic's ThinPrep Pap Tests and Imaging Systems, its ThinPrep 5000 STS (Sample Transfer System), and Cervista MTA (Medium Throughput Automation) systems provide AML with an integrated approach for cervical screening and human papillomavirus (HPV) testing. AML will use Hologic’s cervical screening products in conjunction with its internally-developed HPV PCR detection system which has been validated on more than 500,000 cervical samples and is ISO accredited by the Belgium government. The combined systems are designed to give AML Laboratory an enhanced chain-of-custody procedure allowing for even more confidence in their patient results. 

“After a thorough evaluation of the screening options available to us, we determined that Hologic’s ThinPrep Pap Test and Imaging System offer AML one of the most comprehensive cervical screening technology platforms available”, said Professor Dr. John-Paul Bogers, AML Laboratory Director for Histopathology, Cytopathology and Molecular Pathology. “ThinPrep technology allows us to support a wide range of molecular testing needs today while providing us with flexibility in the future”. 

“We are extremely pleased to enter into this partnership with AML Laboratory”, said Wayne Taylor, Vice President and General Manager, Europe. “These world-class products are designed to provide the most effective and efficient cervical screening technology available to small and medium volume laboratories, while at the same time allowing them the flexibility to address their specific productivity and throughput needs". 

Annie Vereecken, Chief Executive Officer of AML Laboratory added, ”Hologic’s ability to provide a cervical screening platform that provides full automation, workflow efficiencies and patient sample security were key factors in our decision to adopt this technology and use it concurrently with AML’s internally developed HPV detection system”. 

About the Hologic ThinPrep Pap Test and ThinPrep Imaging System: 

The Hologic ThinPrep Pap Test is one of the most widely used methods for cervical screening in the world. 

The ThinPrep process begins with the patient's cervical sample being taken by the physician using a cervical sampling device that, rather than being smeared on a microscope slide as in a conventional Pap smear, is rinsed in a vial filled with Hologic's proprietary PreservCyt solution. This enables most of the patient's cell sample to be preserved before the cells can be damaged by air drying. The ThinPrep specimen vial is then labeled and sent to a laboratory equipped with a ThinPrep processor for slide preparation. 

At the laboratory, the ThinPrep specimen vial is inserted into a ThinPrep processor, a proprietary sample preparation device which automates the process of preparing cervical slides for staining and microscopic examination. In the case of manual screening, the cytotechnologist screens each Pap test slide with a microscope to first determine the adequacy of the slide and to then examine the entire slide to differentiate diseased or abnormal cells from normal cells. 

With the ThinPrep Imaging System, the screening process has been automated to combine the power of computer imaging technology and human interpretive skills. Prior to human review, the ThinPrep Imaging System rapidly scans and locates areas of interest for review. By directing the cytotechnologist to areas of interest on a slide, the system may increase a cytology laboratory's screening productivity and diagnostic accuracy. 

About Hologic, Inc. 
Hologic, Inc. is a leading developer, manufacturer and supplier of premium diagnostic products, medical imaging systems, and surgical products, with an emphasis on serving the healthcare needs of women. The Company operates four core business units focused on diagnostics, breast health, GYN surgical and skeletal health. With a comprehensive suite of technologies and a robust research and development program, Hologic is committed to improving lives. The Company is headquartered in Massachusetts. For more information, visit www.hologic.com. 

Hologic, Cervista, PreservCyt, ThinPrep and associated logos are trademarks and/or registered trademarks of Hologic, Inc. and/or its subsidiaries in the United States and/or other countries. 

Forward-Looking Statement Disclaimer 
This Media Release may contain forward-looking information that involves risks and uncertainties, including statements about Hologic, Inc. and our products. There can be no assurance these products will achieve the benefits described herein and that such benefits will be replicated in any particular manner with respect to an individual patient. Hologic disclaims any obligation to release publicly any updates or revisions to the data or statements presented herein or to reflect any change in our expectations or any change in events, conditions or circumstances on which any such data or statements are based.